Persistent pruritus following COVID-19 vaccination

doi:10.1007/s11845-022-02959-2

. 2023 Feb;192(1):185-186.

doi: 10.1007/s11845-022-02959-2. Epub 2022 Feb 24.

Persistent pruritus following COVID-19 vaccination

C Doyle¹, Richard E Watchorn²

Affiliations

PMID: 35199304
PMCID: PMC8866037
DOI: 10.1007/s11845-022-02959-2

Free PMC article

Persistent pruritus following COVID-19 vaccination

C Doyle et al. Ir J Med Sci. 2023 Feb.

Free PMC article

. 2023 Feb;192(1):185-186.

doi: 10.1007/s11845-022-02959-2. Epub 2022 Feb 24.

Authors

C Doyle¹, Richard E Watchorn²

Affiliations

¹ Department of Dermatology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland. doylec32@tcd.ie.
² Department of Dermatology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.

PMID: 35199304
PMCID: PMC8866037
DOI: 10.1007/s11845-022-02959-2

No abstract available

Keywords: COVID; Drug rash; Pfizer; Phototherapy; Vaccination; mRNA vaccine.

Conflict of interest statement

The authors declare no competing interests.

Figures

**Fig. 1**
Morbilliform rash on trunk and lower limbs

**Fig. 2**
H&E stain showing mild epidermal acanthosis, spongiosis and sub-corneal vesicles. Eosinophils can be seen

See this image and copyright information in PMC

Similar articles

COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
Hause AM, Baggs J, Marquez P, Myers TR, Gee J, Su JR, Zhang B, Thompson D, Shimabukuro TT, Shay DK. Hause AM, et al. MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1755-1760. doi: 10.15585/mmwr.mm705152a1. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34968370 Free PMC article.
Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
Buckley JE, Landis LN, Rapini RP. Buckley JE, et al. JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9. JAAD Int. 2022. PMID: 35156062 Free PMC article.
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG, Hadler SC, Moulia D, Shimabukuro TT, Su JR, Tepper NK, Ess KC, Woo EJ, Mba-Jonas A, Alimchandani M, Nair N, Klein NP, Hanson KE, Markowitz LE, Wharton M, McNally VV, Romero JR, Talbot HK, Lee GM, Daley MF, Mbaeyi SA, Oliver SE. Rosenblum HG, et al. MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34383735 Free PMC article.
Recent COVID-19 vaccination has minimal effects on the physiological responses to graded exercise in physically active healthy people.
Batatinha H, Baker FL, Smith KA, Zúñiga TM, Pedlar CR, Burgess SC, Katsanis E, Simpson RJ. Batatinha H, et al. J Appl Physiol (1985). 2022 Feb 1;132(2):275-282. doi: 10.1152/japplphysiol.00629.2021. Epub 2021 Dec 9. J Appl Physiol (1985). 2022. PMID: 34882029 Free PMC article.
Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
Alamer E, Alhazmi A, Qasir NA, Alamer R, Areeshi H, Gohal G, Qadri M, Hashem AM, Algaissi A. Alamer E, et al. Vaccines (Basel). 2021 Nov 9;9(11):1297. doi: 10.3390/vaccines9111297. Vaccines (Basel). 2021. PMID: 34835228 Free PMC article.

See all similar articles

References

1. Kulkarni RB, Lederman Y, Afiari A, et al. Morbilliform rash: an uncommon herald of SARS-CoV-2. Cureus. 2020;12(7):e9321. doi: 10.7759/cureus.9321. - DOI - PMC - PubMed
1. Jedlowski PM, Jedlowski MF (2021) Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine. Dermatol Online J 27(1). 10.5070/D3271052044https://escholarship.org/uc/item/4xs486zg - PubMed
1. Ohsawa R, Sano H, et al. Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations. J Dermatol Sci Publish. 2021 doi: 10.1016/j.jdermsci.2021.06.006. - DOI - PMC - PubMed
1. Niebel D, Novak N, Wilhelmi J, et al. Cutaneous adverse reactions to COVID-19 vaccines: insights from an immuno-dermatological perspective. Vaccines. 2021;9:944. doi: 10.3390/vaccines909094. - DOI - PMC - PubMed
1. Crisafulli G, Franceschini F, Caimmi S, et al. Mild cutaneous reactions to drugs. Acta Biomed. 2019;90(3-S):36–43. doi: 10.23750/abm.v90i3-S.8159. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Kulkarni RB, Lederman Y, Afiari A, et al. Morbilliform rash: an uncommon herald of SARS-CoV-2. Cureus. 2020;12(7):e9321. doi: 10.7759/cureus.9321. - DOI - PMC - PubMed

[2] Kulkarni RB, Lederman Y, Afiari A, et al. Morbilliform rash: an uncommon herald of SARS-CoV-2. Cureus. 2020;12(7):e9321. doi: 10.7759/cureus.9321. - DOI - PMC - PubMed

[3] Jedlowski PM, Jedlowski MF (2021) Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine. Dermatol Online J 27(1). 10.5070/D3271052044https://escholarship.org/uc/item/4xs486zg - PubMed

[4] Jedlowski PM, Jedlowski MF (2021) Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine. Dermatol Online J 27(1). 10.5070/D3271052044https://escholarship.org/uc/item/4xs486zg - PubMed

[5] Ohsawa R, Sano H, et al. Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations. J Dermatol Sci Publish. 2021 doi: 10.1016/j.jdermsci.2021.06.006. - DOI - PMC - PubMed

[6] Ohsawa R, Sano H, et al. Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations. J Dermatol Sci Publish. 2021 doi: 10.1016/j.jdermsci.2021.06.006. - DOI - PMC - PubMed

[7] Niebel D, Novak N, Wilhelmi J, et al. Cutaneous adverse reactions to COVID-19 vaccines: insights from an immuno-dermatological perspective. Vaccines. 2021;9:944. doi: 10.3390/vaccines909094. - DOI - PMC - PubMed

[8] Niebel D, Novak N, Wilhelmi J, et al. Cutaneous adverse reactions to COVID-19 vaccines: insights from an immuno-dermatological perspective. Vaccines. 2021;9:944. doi: 10.3390/vaccines909094. - DOI - PMC - PubMed

[9] Crisafulli G, Franceschini F, Caimmi S, et al. Mild cutaneous reactions to drugs. Acta Biomed. 2019;90(3-S):36–43. doi: 10.23750/abm.v90i3-S.8159. - DOI - PMC - PubMed

[10] Crisafulli G, Franceschini F, Caimmi S, et al. Mild cutaneous reactions to drugs. Acta Biomed. 2019;90(3-S):36–43. doi: 10.23750/abm.v90i3-S.8159. - DOI - PMC - PubMed

Conflict of interest statement

Figures

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources